Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New JAK inhibitors synthesized at Guangzhou Innocare Pharma Tech

Jan. 19, 2021

Guangdong Newopp Biopharmaceuticals identifies mutant KRAS inhibitors

Jan. 19, 2021

Hangzhou Hertz Pharmaceutical patents casein kinase 1 isoform epsilon inhibitors

Jan. 19, 2021

New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery

Jan. 19, 2021

Enrollment opens in phase II study of vactosertib plus pembrolizumab in NSCLC

Jan. 19, 2021

BET inhibitors synergize with BCL-2 or HDAC inhibitors in Waldenstrom macroglobulinemia

Jan. 19, 2021

Phase II data reported for cabozantinib in type I neurofibromatosis with PNs

Jan. 19, 2021

Dosing begins in phase IIa study of STP-705 for cutaneous basal cell carcinoma

Jan. 18, 2021

Nanjing Sanhome Pharmaceutical patents PRMT5 inhibitors

Jan. 18, 2021

CCS-1477, novel p300/CBP inhibitor with promising activity in prostate cancer

Jan. 18, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...